Max Siurala Award

In 1988 the Finnish Society of Gastroenterology founded an annual award in honour of Professor Max Siurala to recognize his distinguished scientific research in the field of gastroenterology.

Since 1993 the Award has included the Max Siurala Medal designed by Toivo Jaatinen. The Award is supported by Orion Pharma Finland.

Professor Siurala was born on 21 October 1913 and passed away on 6 September 2003.



Professor Hannele Yki-Järvinen

Helsinki, Finland



Professor Urban Arnelo

Umeå, Sweden





Professor Katri Kaukinen

Tampere, Finland



Professor Caj Haglund

Helsinki, Finland



Séverine Vermeire 

Leuven, Belgium

Séverine Vermeire graduated as MD at the KU Leuven. Part of her training was done at the Universidad Nacional de Asuncion, Paraguay (1993), and at the Montreal General Hospital (McGill University), Montreal, Canada (2000–2001). In 2001, she obtained her PhD on Genetic Polymorphisms and Serologic Markers in Inflammatory Bowel Disease as a Fellow of the Funds for Scientific Research (FWO) Belgium. Part of her PhD was done at the University of Oxford, UK, at the Wellcome Trust Centre for Human Genetics with Professor Derek Jewell. Since 2003 she was appointed staff member at the University Hospitals Leuven (Division of Gastroenterology & Hepatology) and is appointed Professor of Medicine at the KU Leuven. She is Head of the Department of Clinical and Experimental Medicine et KU Leuven.

Her scientific work focusses on genetics and pharmacogenetics of IBD, on the role of the microbiome in IBD and on aspects related to immunogenicity of biological therapies. These research lines have resulted in >300 peer-reviewed full papers and an h-index of 76. In 2016 she was awarded an Advanced ERC Research Grant.

She served as Associate Editor for GUT from 2004-2010 and is currently Associate Editor for the Journal of Crohn’s and Colitis. Dr Vermeire is Past-President of the Belgian IBD Research and Development Group (BIRD) and Past- President of the European Crohn’s and Colitis Organisation (ECCO).


Professor Peter D. Siersema

Rotterdam, Netherlands



Professor Han-Kwang Yang

Seoul, Korea



Professor Jukka-Pekka Mecklin

Jyväskylä, Finland



Professor Martti Färkkilä

Helsinki, Finland



Professor Markku Mäki

Tampere, Finland




Professor Risto Rintala

Helsinki, Finland



Professor Pentti Sipponen

Helsinki, Finland


Professor Tuula Kiviluoto, Helsinki, Finland
Haimasyöpä - kirurgisen hoidon kehitys
18 February 2010

MD, PhD Marja Boermeester, Department of Surgery, Academic Medical Center, Amsterdam, the Netherlands
Diagnosis and treatment of peritonitis
12 February 2009

Professor Mikko Salaspuro, Helsinki, Finland
Alkoholi ja ruuansulatuskanavan syöpä
15 February 2008

Professor Krister Höckerstedt, Helsinki University Hospital, Helsinki, Finland
Klinikasta maksatutkimuksiin
15 February 2007

Professor Barry J Marshall, Perth, Australia
The relation of Helicobacter pylori to gastric malignancy
7 September 2006

Professor Markus Büchler, Heidelberg, Germany
Modern management of the carcinoma in the head of the pancreas
17 February 2005

Professor Heikki Järvinen, Helsinki University Hospital, Helsinki, Finland
Treatment and prevention of hereditary colon cancer
11 March 2004

Professor Michael Peter Manns, Hannover, Germany
Autoimmunity in Liver Disease
6 March 2003

Professor Michel Cremer, Erasme Hospital, Brussels, Belgium
Endoscopic treatment of chronic pancreatitis
7 March 2002

Professor Tetsuichiro Muto, The Cancer Institute Hospital, Tokyo, Japan
Optimal performance of screening colonoscopy with special reference on diminutive and flat adenomas
15 March 2001

Professor Rune Sjödahl, University Hospital, Linköping, Sweden
The role of surgery in Crohn’s disease – where are we now
11 February 2000

Professor Colm O’Morain, the Adelaide and Meath Hospitals, Tallaght, and Trinity College, Dublin, Ireland
Dyspepsia – still causes maldigestion
2 September 1999

Professor Erik Schrumpf, the National Hospital, Rikshospitalet, Oslo, Norway
Cholestatic liver diseases
4 June 1998

Professor Tore Scherstén, Sahlgrenska Hospital, Göteborg, Sweden
Adjuvant treatment of liver malignancies
13 March 1997

Dr Gunnar Järnerot, Regional Hospital, Örebro, Sweden
Medical therapy in IBD
14 March 1996

Dr Friedrich Hagenmüller, Allgemeines Krankenhaus Altona, Hamburg, Germany
Quality assurance in endoscopy
16 March 1995

Dr Robert Heading, the Royal Infirmary, University of Edinburgh, UK
What is dyspepsia?
10 March 1994

Professor David Skinner, New York, USA
Antireflux surgery – when? how?
27 May 1993

Professor Guido Tytgat, the Academic Medical Centre, Amsterdam, The Netherlands
Gastrointestinal endoscopy in 2000
12 March 1992

Professor Juan-Ramón Malagelada Benaprès, the Hospital General Vall d’Hebron, the Autonomous University of Barcelona, Barcelona, Spain
Chaos and order in gastrointestinal motility
14 March 1991

Professor Peter Scheuer, the Royal Free Hospital, London, UK
Changing views on chronic hepatitis
15 March 1990

Professor Håkan Ahlman, Sahlgrenska Hospital, Göteborg, Sweden
The enterochromaffin cell system in health anddisease and neural influences on endocrine and immune functions of the gut
30 March 1989

Professor J H Baron, the Royal Postgraduate Medical School of the University of London, UK
The history of gastric secretion
3 June 1988

Max Siurala